Streetbeat News

Price Targets

GM

Mizuho analyst Vijay Rakesh has upgraded General Motors (NYSE:GM) from Neutral to Buy and increased the price target from $38 to $42.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 10:50 am

EWBC

Morgan Stanley analyst Manan Gosalia upgraded East West Bancorp (NASDAQ:EWBC) from Equal-Weight to Overweight and increased the price target from $66 to $76.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 10:44 am

RXST

Morgan Stanley analyst Patrick Wood has initiated coverage on RxSight (NASDAQ:RXST) with an Overweight rating and set a price target of $36 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 10:40 am

HUBB

Barclays analyst Julian Mitchell has initiated coverage on Hubbell (NYSE:HUBB) with an Equal-Weight rating and set a price target of $325 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 10:38 am

WS

Keybanc analyst Philip Gibbs has initiated coverage on Worthington Steel (NYSE:WS) with an Overweight rating and set a price target of $29.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 10:34 am

IMGN

Barclays analyst Peter Lawson has downgraded Immunogen (NASDAQ:IMGN) from Overweight to Equal-Weight, while also raising the price target for the company's stock from $27 to $31.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 10:31 am

ALC

Morgan Stanley analyst Patrick Wood downgraded Alcon (NYSE:ALC) from Equal-Weight to Underweight and set a price target of $65.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 10:27 am

ALLE

Barclays analyst Julian Mitchell downgraded Allegion (NYSE:ALLE) from Overweight to Equal-Weight and reduced the price target from $130 to $119.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 10:24 am

MMM

Barclays analyst Julian Mitchell upgraded 3M (NYSE:MMM) from Underweight to Equal-Weight and increased the price target from $98 to $107, indicating a more favorable outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 10:20 am

SIBN

Needham analyst David Saxon has reiterated a Buy rating on SI-BONE (NASDAQ:SIBN) and maintained a $25 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 10:17 am